Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KS › Atchison › NPI 1932151487
Hospital

Amberwell Atchison Association

Amberwell Atchison Association was paid $1.22M by Medicaid between Jan 2018 and Nov 2024, across 55 billing codes. Its largest line is 99283, emergency room visit (moderate) — 32% of everything it billed.

33Billing provider infoAMBERWELL ATCHISON ASSOCIATION
ATCHISON, KS 66002
33aNPI1932151487assigned 05/16/2006
33bProvider typeCritical Access Hospital
28Total paid$1.22M
24GClaims45,647
24DCodes billed55
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Critical Access Hospital providers in Kansas

Rank by total paid#4 of 74
Median peer was paid$11K
This provider vs. median111×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K$60K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20189,958$236K
20196,075$186K
20204,140$119K
20218,354$219K
20229,173$253K
20236,211$150K
2024incomplete1,736$59K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 32% 7,887 6,239 $398K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 4,364 3,387 $217K
99282 Emergency department visit for the evaluation and management, low to moderate severity 17% 4,253 3,566 $210K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 9.1% 1,336 1,084 $112K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6.0% 513 478 $73K
80053 Comprehensive metabolic panel 4.7% 4,561 3,880 $57K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2.6% 236 219 $31K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.3% 4,682 4,045 $28K
96361 Intravenous infusion, hydration; each additional hour <1% 293 239 $10K
81001 <1% 2,081 1,846 $10K
96375 Therapeutic injection; each additional sequential IV push <1% 182 150 $10K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 343 291 $9K
43 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 162 $8K
99070 <1% 926 $7K
84443 Thyroid stimulating hormone (TSH) <1% 534 $6K
36415 Collection of venous blood by venipuncture <1% 8,832 $5K
71045 Radiologic examination, chest; single view <1% 370 $4K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 34 $3K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 15 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 166 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 153 $2K
71046 Radiologic examination, chest; 2 views <1% 82 $2K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 297 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 67 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 98 $2K
G0381 Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 43 $1K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 19 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 38 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 63 $922.13
80048 Basic metabolic panel (calcium, ionized) <1% 142 $881.61
84484 <1% 72 $809.38
81025 <1% 64 $730.60
85610 <1% 186 $720.82
80061 Lipid panel <1% 53 $666.84
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 20 $645.88
83690 <1% 65 $586.07
83605 <1% 52 $584.24
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 42 $538.82
85027 <1% 61 $439.29
87184 <1% 40 $412.16
85730 <1% 46 $238.53
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 48 $149.61
83735 <1% 18 $142.29
87081 <1% 13 $138.37
84439 <1% 15 $120.07
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 92 $94.02
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 59 $75.10
85007 <1% 38 $68.32
J2704 Injection, propofol, 10 mg <1% 451 $58.84
J7030 Infusion, normal saline solution , 1000 cc <1% 217 $23.68
J3010 Injection, fentanyl citrate, 0.1 mg <1% 35 $23.39
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 1,128 $6.48
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml 0% 18 $0.00
82607 0% 25 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABEL, JARED (CEO)
Parent organizationAMBERWELL ATCHISON ASSOCIATION
Same official

Other billing entities under ABEL, JARED

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.